{
    "nctId": "NCT04351139",
    "briefTitle": "Impact of the COVID-19 Pandemic in Gynecological Oncology",
    "officialTitle": "Impact of the COVID-19 Pandemic on Changes in Therapeutic Strategies in Gynecological Oncology",
    "overallStatus": "COMPLETED",
    "conditions": "Gynecologic Cancer, Breast Neoplasm Female, Uterine Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Vaginal Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 205,
    "primaryOutcomeMeasure": "percentage of patients with a change in the planned therapeutic management (surgery, chemotherapy, radiotherapy, hormone therapy)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women over 18\n* gynecological cancer (breast cancer, uterus, ovary, cervix, vagina or vulva cancer)\n* therapeutic management planned during quarantine\n* person having expressed his non-opposition\n\nInclusion Criteria of control group :\n\n* women over 18\n* gynecological cancer (breast, uterus, ovary, cervix, vagina or vulva cancer)\n* therapeutic management planned on the end of the year 2019\n* person having expressed his non-opposition\n\nExclusion Criteria:\n\n* inability to understand the information given\n* person deprived of liberty,\n* person under guardianship.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}